As of 2026-04-15, the Relative Valuation of Utah Medical Products Inc (UTMD) is 123.59 USD. This relative valuation is based on P/E multiples. With the latest stock price at 68.37 USD, the upside of Utah Medical Products Inc based on Relative Valuation is 80.8%.
The range of the Relative Valuation is 114.23 - 138.33 USD.
| Range | Selected | |
| Trailing P/E multiples | 34.8x - 39.1x | 37.0x |
| Forward P/E multiples | 30.7x - 31.9x | 31.3x |
| Fair Price | 114.23 - 138.33 | 123.59 |
| Upside | 67.1% - 102.3% | 80.8% |
| Date | P/E |
| 2026-04-14 | 19.32 |
| 2026-04-13 | 18.98 |
| 2026-04-10 | 18.63 |
| 2026-04-09 | 18.33 |
| 2026-04-08 | 18.24 |
| 2026-04-07 | 17.94 |
| 2026-04-06 | 17.79 |
| 2026-04-02 | 17.84 |
| 2026-04-01 | 17.77 |
| 2026-03-31 | 17.52 |
| 2026-03-30 | 18.31 |
| 2026-03-27 | 17.39 |
| 2026-03-26 | 17.69 |
| 2026-03-25 | 18.01 |
| 2026-03-24 | 18.03 |
| 2026-03-23 | 18.41 |
| 2026-03-20 | 18.27 |
| 2026-03-19 | 18.09 |
| 2026-03-18 | 18.20 |
| 2026-03-17 | 18.10 |
| 2026-03-16 | 18.09 |
| 2026-03-13 | 17.89 |
| 2026-03-12 | 17.71 |
| 2026-03-11 | 18.02 |
| 2026-03-10 | 18.03 |
| 2026-03-09 | 18.10 |
| 2026-03-06 | 18.41 |
| 2026-03-05 | 18.43 |
| 2026-03-04 | 18.71 |
| 2026-03-03 | 18.80 |
| 2026-03-02 | 18.96 |
| 2026-02-27 | 18.83 |
| 2026-02-26 | 18.81 |
| 2026-02-25 | 19.13 |
| 2026-02-24 | 18.86 |
| 2026-02-23 | 18.92 |
| 2026-02-20 | 19.17 |
| 2026-02-19 | 18.82 |
| 2026-02-18 | 18.26 |
| 2026-02-17 | 18.47 |
| 2026-02-13 | 18.12 |
| 2026-02-12 | 18.01 |
| 2026-02-11 | 18.15 |
| 2026-02-10 | 18.23 |
| 2026-02-09 | 17.63 |
| 2026-02-06 | 17.42 |
| 2026-02-05 | 17.77 |
| 2026-02-04 | 17.49 |
| 2026-02-03 | 17.53 |
| 2026-02-02 | 17.46 |